Article
Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse.
PloS one - 1 Jan 2012
Dillon Lloye M, Hida Aline, Garcia Sofia, Prolla Tomas A, Moraes Carlos T
Abstract excerpt
Pharmacological agents, such as bezafibrate, that activate peroxisome proliferator-activated receptors (PPARs) and PPAR γ coactivator-1α (PGC-1α) pathways have been shown to improve mitochondrial function and energy metabolism. The mitochondrial DNA (mtDNA) mutator mouse is a mouse model of aging that harbors a proofreading-deficient mtDNA polymerase γ. These mice develop many features of premature aging...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
